J. E. Glusman
- Genetics top 2%
- Oncology top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Cancer Research top 5%
- Molecular Biology
- Co-authors
- Stephen EckertThomas NickélsenSteven R. CummingsLarry NortonMarc E. LippmanJane A. CauleyMonica MorrowV. Craig Jordan
- Topics
- Pituitary Gland Disorders and Treatments (6 papers)Estrogen and related hormone effects (4 papers)Breast Cancer Treatment Studies (3 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
J. E. Glusman
17 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Genetics 1.1k
- Oncology 794
- Endocrinology, Diabetes and Metabolism 751
- Cancer Research 369
- Molecular Biology 358
Countries citing papers authored by J. E. Glusman
This map shows the geographic impact of J. E. Glusman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. E. Glusman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. E. Glusman more than expected).
Fields of papers citing papers by J. E. Glusman
This network shows the impact of papers produced by J. E. Glusman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. E. Glusman. The network helps show where J. E. Glusman may publish in the future.
Co-authorship network of co-authors of J. E. Glusman
This figure shows the co-authorship network connecting the top 25 collaborators of J. E. Glusman. A scholar is included among the top collaborators of J. E. Glusman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. E. Glusman. J. E. Glusman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 207 | |
| 3 | pasireotide LAR is effective in patients | 1 |
| 4 | Pasireotide (SOM230) effectively reduces pituitary tumor volume in patients with active acromegaly: preliminary 6-month results from a phase II extension study | 6 |
| 5 | 187 | |
| 6 | The effects of pasireotide (SOM230) on glucose metabolism and growth hormone (GH) nadir during oral glucose tolerance test (OGTT) in 12 patients with acromegaly from a Phase II study | 1 |
| 7 | 10 | |
| 8 | 48 | |
| 9 | 11 | |
| 10 | 73 | |
| 11 | 76 | |
| 12 | The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Womenbreakdown → | 1398 |
| 13 | 12 | |
| 14 | 4 | |
| 15 | 45 | |
| 16 | 1 | |
| 17 | 5 |
About J. E. Glusman
J. E. Glusman is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology and Oncology, having authored 17 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (6 papers), Estrogen and related hormone effects (4 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (751 citations), Genetics (1.1k citations) and Orthopedics and Sports Medicine (318 citations). J. E. Glusman has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Stephen Eckert, Thomas Nickélsen, Steven R. Cummings, Larry Norton, Marc E. Lippman, Jane A. Cauley, Monica Morrow, V. Craig Jordan, A. Costa and Debra Black. Their work appears in journals such as JAMA, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.